These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31213295)

  • 1. Therapeutic impact of orally administered cannabinoid oil extracts in an experimental autoimmune encephalomyelitis animal model of multiple sclerosis.
    Zhou T; Ahmad TK; Alrushaid S; Pozdirca M; Ethans K; Intrater H; Le T; Burczynski F; Kong J; Namaka M
    Biochem Biophys Res Commun; 2019 Aug; 516(2):373-380. PubMed ID: 31213295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental Autoimmune Encephalomyelitis (EAE)-Induced Elevated Expression of the E1 Isoform of Methyl CpG Binding Protein 2 (MeCP2E1): Implications in Multiple Sclerosis (MS)-Induced Neurological Disability and Associated Myelin Damage.
    Khorshid Ahmad T; Zhou T; AlTaweel K; Cortes C; Lillico R; Lakowski TM; Gozda K; Namaka MP
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28604632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of a novel cannabinoid agent CB52 in the mouse model of experimental autoimmune encephalomyelitis.
    Ribeiro R; Yu F; Wen J; Vana A; Zhang Y
    Neuroscience; 2013 Dec; 254():427-42. PubMed ID: 24036373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and chronic cannabinoid extracts administration affects motor function in a CREAE model of multiple sclerosis.
    Buccellato E; Carretta D; Utan A; Cavina C; Speroni E; Grassi G; Candeletti S; Romualdi P
    J Ethnopharmacol; 2011 Feb; 133(3):1033-8. PubMed ID: 21094240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing Neuropathic Pain in Multiple Sclerosis: Pharmacological Interventions.
    Duffy SS; Lees JG; Perera CJ; Moalem-Taylor G
    Med Chem; 2018 Feb; 14(2):106-119. PubMed ID: 28875858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-inflammatory and analgesic effects of formulated full-spectrum cannabis extract in the treatment of neuropathic pain associated with multiple sclerosis.
    Maayah ZH; Takahara S; Ferdaoussi M; Dyck JRB
    Inflamm Res; 2020 Jun; 69(6):549-558. PubMed ID: 32239248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of cannabinoid CB2 receptors reduces hyperalgesia in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
    Fu W; Taylor BK
    Neurosci Lett; 2015 May; 595():1-6. PubMed ID: 25849525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
    Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
    Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental autoimmune encephalomyelitis-induced upregulation of tumor necrosis factor-alpha in the dorsal root ganglia.
    Melanson M; Miao P; Eisenstat D; Gong Y; Gu X; Au K; Zhu W; Begum F; Frost EE; Namaka M
    Mult Scler; 2009 Oct; 15(10):1135-45. PubMed ID: 19667008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing the BDNF and NGF loss involved in the effects of cornel iridoid glycoside on attenuation of experimental autoimmune encephalomyelitis in mice.
    Qu Z; Zheng N; Zhang Y; Zhang L; Liu J; Wang Q; Yin L
    Neurol Res; 2016 Sep; 38(9):831-7. PubMed ID: 27373350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purified Cannabidiol, the main non-psychotropic component of Cannabis sativa, alone, counteracts neuronal apoptosis in experimental multiple sclerosis.
    Giacoppo S; Soundara Rajan T; Galuppo M; Pollastro F; Grassi G; Bramanti P; Mazzon E
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4906-19. PubMed ID: 26744883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avidekel Cannabis extracts and cannabidiol are as efficient as Copaxone in suppressing EAE in SJL/J mice.
    Gallily R; Yekhtin Z
    Inflammopharmacology; 2019 Feb; 27(1):167-173. PubMed ID: 30291491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
    Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
    Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, tolerability, and efficacy of orally administered cannabinoids in MS.
    Russo EB
    Neurology; 2003 Feb; 60(4):729-30; author reply 729-30. PubMed ID: 12601130
    [No Abstract]   [Full Text] [Related]  

  • 15. Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods.
    Khan N; Woodruff TM; Smith MT
    Pharmacol Biochem Behav; 2014 Nov; 126():13-27. PubMed ID: 25223977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Exercise Training and Royal Jelly on Hippocampal Cannabinoid-1-Receptors and Pain Threshold in Experimental Autoimmune Encephalomyelitis in Rats as Animal Model of Multiple Sclerosis.
    Kheirdeh M; Koushkie Jahromi M; Brühl AB; Brand S
    Nutrients; 2022 Oct; 14(19):. PubMed ID: 36235771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of JAK/STAT signaling in the effect of cornel iridoid glycoside on experimental autoimmune encephalomyelitis amelioration in rats.
    Yin L; Chen Y; Qu Z; Zhang L; Wang Q; Zhang Q; Li L
    J Neuroimmunol; 2014 Sep; 274(1-2):28-37. PubMed ID: 25012120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical moringin-cream relieves neuropathic pain by suppression of inflammatory pathway and voltage-gated ion channels in murine model of multiple sclerosis.
    Giacoppo S; Iori R; Bramanti P; Mazzon E
    Mol Pain; 2017; 13():1744806917724318. PubMed ID: 28741431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis and Cannabinoids in Multiple Sclerosis: From Experimental Models to Clinical Practice-A Review.
    Sirbu CA; Georgescu R; Pleşa FC; Paunescu A; Marilena Ţânţu M; Nicolae AC; Caloianu I; Mitrica M
    Am J Ther; 2023 May; 30(3):e220-e231. PubMed ID: 37278703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The modulatory effects of luteolin on cyclic AMP/Ciliary neurotrophic factor signaling pathway in experimentally induced autoimmune encephalomyelitis.
    El-Deeb OS; Ghanem HB; El-Esawy RO; Sadek MT
    IUBMB Life; 2019 Sep; 71(9):1401-1408. PubMed ID: 31185137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.